Back to Search Start Over

Different binding to DNA of enantiomeric platinum complexes assessed by inhibition of restriction enzyme activity.

Authors :
Coluccia M
Giordano D
Loseto F
Intini FP
Maresca L
Natile G
Source :
Anticancer research [Anticancer Res] 1989 May-Jun; Vol. 9 (3), pp. 795-8.
Publication Year :
1989

Abstract

The ability of enantiomeric platinum complexes to block the action of selected restriction enzymes has been investigated. The complexes [PtCl2(DAC)], [PtCl2(DAB)] and [PtCl2(DAP)] (DAC = 1,2-diamminocyclohexane; DAB = 2,3-diamminobutane; DAP = 1,2-diamminopropane) exhibit a guanine-cytosine preference in accord with previous results on cis-[PtCl2(NH3)2] (cis-DDP). The extent of inhibition, however, is significantly different for the different isomers; the R,R form is more active than the others at short incubation time, as the time becomes longer, the differences among isomers level off. It also appears that cis-DDP is more active than [PtCl2(DAC)] in blocking the Cfo I enzyme, though it shows a preference for the G-X-G sequences.

Details

Language :
English
ISSN :
0250-7005
Volume :
9
Issue :
3
Database :
MEDLINE
Journal :
Anticancer research
Publication Type :
Academic Journal
Accession number :
2548438